This audio is automatically generated. Please let us know if you have any comments.
Morrisville, North Carolina-based design-build construction management firm BE&K Building Group has won a contract to build 10 or more manufacturing buildings for pharmaceutical company Novo Nordisk in Clayton, North Carolina. the company announced on June 24.
The Bagsværd, Denmark-based pharmaceutical company will invest $4.1 billion in the facility, according to a company fact sheet. The project will increase Novo Nordisk’s capacity to produce injectable treatments for people with obesity and other serious chronic diseases. Novo Nordisk makes medicines like Ozempic and Wegovywhich are used for the treatment of diabetes and weight loss and have seen a surge in demand over the past year.
BE&K has already spent two years planning the project, including providing budgets, schedules and procurement strategies, and now construction has officially begun.
The project will create more than 1.4 million square feet across the many buildings on the 56-acre property, according to the release. BE&K will perform a significant portion of the work as construction manager and act as agency construction manager for the remainder of the work.
The facility is being built across the street from an existing Novo Nordisk site, but the new one will be about four times the size of the original. Novo Nordisk has three current manufacturing facilities in North Carolina, and the new Clayton site will double the floor space of those combined facilities, according to the company’s fact sheet.
Construction will conclude in phases from 2027 to 2029, according to the release, and the project will seek LEED-Gold certification for the various buildings.
